Delivery Order SPE2DB20D1100-SPE2DB24FB6N7

Award Date 5/6/24
Potential Completion Date 5/7/24
Potential Value $2.2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The $10,970.80 firm-fixed-price delivery order is for the pharmaceutical product WEGOVY 0.25 MG/0.5 ML PEN 0.5ML, with a completion date of June 24, 2024. Amerisourcebergen, a major supplier of pharmaceutical products and medical supplies to the U.S. government, holds a single-award Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 with DLA...
This federal contract award was granted to Amerisourcebergen Drug Corp's Corporate Office Division, a major supplier of pharmaceutical products and medical supplies to the U.S. government. The contract, with a ceiling value of $2,697.62, is a Delivery Order from the Defense Logistics Agency (DLA), a defense agency, for the delivery of the pharmaceutical product WEGOVY 1 MG/0.5 ML PEN 0.5ML. The contract is a Firm Fixed Price arrangement with an ultimate completion date of April 23, 2024....
The U.S. government's Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp a delivery order contract worth $12,850.04 for the pharmaceutical product WEGOVY 0.25 MG/0.5 ML PEN 0.5ML. This order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. Under this IDC, Amerisourcebergen provides a comprehensive range of pharmaceutical products and medical supplies to support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The $15,359.12 Firm Fixed Price Delivery Order is for the supply of the prescription medication WEGOVY 0.25 MG/0.5 ML PEN 0.5ML. The contract has an ultimate completion date of July 16, 2024. Amerisourcebergen is a major pharmaceutical distributor that holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical to provide a...
This federal contract award, valued at $7,448.81, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of WEGOVY 0.5 MG/0.5 ML PEN 0.8ML, a medical product. The contract has an ultimate completion date of January 24, 2025 and is a firm fixed-price contract. Amerisourcebergen Drug Corp is the prime contractor, and the contract was not set aside for...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the supply of the prescription medication WEGOVY 0.5 MG/0.5 ML PEN 0.5ML. The contract, awarded by the Defense Logistics Agency (DLA), has a ceiling value of $2,942.47 and is a Firm Fixed Price Delivery Order. The contract has an ultimate completion date of May 30, 2024. Amerisourcebergen, a major pharmaceutical distribution company, has an extensive Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $9,768.89 firm-fixed-price delivery order is for the drug WEGOVY 0.5 MG/0.5 ML PEN 0.5ML, with a completion date of October 17, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office division is a Delivery Order valued at $3,291.24 for the pharmaceutical product WEGOVY 2.4 MG/0.75 ML PEN 0.75ML. The award was made by the Defense Logistics Agency (DLA), a defense agency. This appears to be a supplemental order under a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for delivering a range of medical...
The Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a Delivery Order contract worth $17,278.79 for the pharmaceutical product WEGOVY 2.4 MG/0.75 ML PEN 0.75ML. This Delivery Order contract has a firm fixed price and an ultimate completion date of April 25, 2024. Amerisourcebergen Drug Corp's Corporate Office Division is the prime contractor and there is no set-aside designation for this award. Amerisourcebergen Drug Corp holds...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division, valued at $2,194.16, is for the delivery of the pharmaceutical product WEGOVY 0.25 MG/0.5 ML PEN 0.5ML. The contract is a Firm Fixed Price Delivery Order placed by the Defense Logistics Agency (DLA), a defense agency. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025, which serves as the primary...
  • SPE2DB20D1100
    Indefinite Delivery Contract
  • SPE2DB20D1100-SPE2DB24FB6N7
    Delivery Order

This federal contract award, valued at $2,194.16, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of the pharmaceutical product WEGOVY 0.25 MG/0.5 ML PEN 0.5ML. The contract has an ultimate completion date of May 7, 2024 and is a firm fixed-price delivery order. Amerisourcebergen Drug Corp, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. The contract does not have a set-aside designation.

Generated 8/5/24, 9:20 AM